NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

AMC's Q2 2025: Box Office Boom & Premium Success

AMC's Q2 saw a narrowed loss, boosted by a rebounding box office & premium experiences. Revenue hit $1.4B, adjusted EBITDA soared 150%, and per-patron spending hit records, strengthening the balance sheet for future growth.

AMC's Q2 2025: Box Office Boom & Premium Success
Photo by Martin Makaryan on Unsplash

This post is for paying subscribers only

Already have an account? Sign in.
08/11/2025 · 12:18 PM
AMC
/ Read more

Feed↓

Pokémon Pokopia: The Cozy Hit That's Selling Out and Skyrocketing Nintendo Shares
03/11/2026 · 11:38 AM

Pokémon Pokopia: The Cozy Hit That's Selling Out and Skyrocketing Nintendo Shares

Pokémon Pokopia, a cozy Animal Crossing-style life sim for Switch 2, is selling out at retailers and sending Nintendo shares up 6% in the U.S.

/ Subscriber only
Tesla China Roars Back: 58,599 Vehicles Sold in February, Fourth Straight Month of Gains
Featured/ 03/11/2026 · 11:11 AM

Tesla China Roars Back: 58,599 Vehicles Sold in February, Fourth Straight Month of Gains

Tesla China's February 2026 wholesale sales hit 58,599 vehicles, up 91% year-over-year from a low base in 2025. Despite a monthly dip, exports surged and financing deals help boost demand in a competitive market.

/ Subscriber only
Wells Fargo gives Atrium Therapeutics a Strong Buy rating on its rare cardiomyopathy programs
03/11/2026 · 10:15 AM

Wells Fargo gives Atrium Therapeutics a Strong Buy rating on its rare cardiomyopathy programs

Wells Fargo analyst initiates coverage on Atrium Therapeutics with Overweight rating and $25 price target, highlighting big potential in RNA therapies for rare genetic heart diseases with no current treatments.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe